ABBV•benzinga•
AbbVie's RINVOQ Receives European Commission Approval As First And Only Oral JAK Inhibitor For Adults With Giant Cell Arteritis
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on April 8, 2025 by benzinga